Djordjevic-Jovanovic Lidija, Karanikolic Aleksandar, Bojic Toplica, Pesic Ivan, Djordjevic Miodrag, Marinkovic Mirjana
Surgical Clinic Nis ,Clinical Center Nis, Nis, Serbia.
J BUON. 2017 May-Jun;22(3):652-657.
The clinical behavior and outcome of multifocal (MF) and multicentric (MC) breast tumors are not well characterized. The purpose of this study was to compare the prognosis of MF/MC tumors with unifocal (UF)tumors and its correlation with other pathological characteristics and patient outcomes.
Eighty-three patients with MC/MF breast cancer and 501 with UF breast cancer treated at the Surgical Clinic Nis were studied. We compared MC/MF and UF breast cancer patients with respect to demographics, tumor characteristics- adjuvant systemic therapy, local recurrence-free survival (LRFS) and overall survival (OS).
There was no significant statistical difference between the two groups with respect to mean age at diagnosis, tumor grade, nodal status, estrogen receptor status, lymphovascular invasion (LVI) and adjuvant systemic therapy. The MC/MF group had more patients with modified radical mastectomy and the UF group had more patients with breast-conserving surgery. Cox multivariate regression analysis showed that the regional lymph node metastases and LVI were the most important predictors of 5-year OS rate. During this period, locoregional recurrence was registered in 29 (5.78%) patients in the UF group and in 5 (6.02%) patients in the MF/MC group (p=0.48). No statistically significant differences in the 5-year LRFS and OS between the two groups were noticed.
The prognostic value of MF/MC disease is still not well known, although some studies have suggested that it is associated with a worse prognosis. This study showed no statistically significant difference in the 5-year LRFS and OS between UF and MF/MC groups.
多灶性(MF)和多中心性(MC)乳腺肿瘤的临床行为及转归尚未得到充分描述。本研究旨在比较MF/MC肿瘤与单灶性(UF)肿瘤的预后及其与其他病理特征和患者转归的相关性。
对在尼什外科诊所接受治疗的83例MC/MF乳腺癌患者和501例UF乳腺癌患者进行了研究。我们比较了MC/MF和UF乳腺癌患者在人口统计学、肿瘤特征、辅助全身治疗、无局部复发生存率(LRFS)和总生存率(OS)方面的情况。
两组在诊断时的平均年龄、肿瘤分级、淋巴结状态、雌激素受体状态、淋巴管浸润(LVI)和辅助全身治疗方面无显著统计学差异。MC/MF组接受改良根治术的患者更多,UF组接受保乳手术的患者更多。Cox多因素回归分析显示,区域淋巴结转移和LVI是5年OS率的最重要预测因素。在此期间,UF组有29例(5.78%)患者出现局部区域复发,MF/MC组有5例(6.02%)患者出现局部区域复发(p = 0.48)。两组在5年LRFS和OS方面未观察到统计学显著差异。
尽管一些研究表明MF/MC疾病与较差的预后相关,但其预后价值仍未完全明确。本研究显示UF组和MF/MC组在5年LRFS和OS方面无统计学显著差异。